We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+11.67%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$9.22B
AUM Growth
+$331M
(+3.7%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-4.02%
Top 10 Holdings %
Top 10 Hldgs %
56.36%
Holding
1,043
New
155
Increased
182
Reduced
486
Closed
210
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hess Midstream
HESM
|
+$149M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$105M |
| 3 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$97.9M |
| 4 |
MPLX
MPLX
|
+$74.6M |
| 5 |
DCP
DCP Midstream, LP
DCP
|
+$63.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Western Midstream Partners
WES
|
+$541M |
| 2 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
+$338M |
| 3 |
Williams Companies
WMB
|
+$35.8M |
| 4 |
ExxonMobil
XOM
|
+$29.6M |
| 5 |
Verizon
VZ
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 65.72% |
| 2 | Technology | 5.09% |
| 3 | Consumer Discretionary | 3.8% |
| 4 | Healthcare | 3.45% |
| 5 | Industrials | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPHA
776
Innate Pharma
IPHA
$171M
| $282K | ﹤0.01% |
83,966
-9,752
| -10% | -$36K |
|
777
IQVIA
IQV
$35.2B
| $275K | ﹤0.01% |
1,190
-60
| -5% | -$14.2K |
|
|
LGVN
778
Longeveron
LGVN
$19.4M
| $271K | ﹤0.01% |
1,966
-246
| -11% | -$18.5K |
|
|
ALPN
779
DELISTED
Alpine Immune Sciences Inc
ALPN
| $269K | ﹤0.01% |
30,030
-3,785
| -11% | -$32.7K |
|
780
Alphabet (Google) Class C
GOOG
$4.01T
| $268K | ﹤0.01% |
1,920
-540
| -22% | -$73.4K |
|
781
ITT
ITT
$17.5B
| $267K | ﹤0.01% |
3,556
+150
| +4% | +$13.2K |
|
782
SPS Commerce
SPSC
$2.41B
| $266K | ﹤0.01% |
2,030
-345
| -15% | -$43.2K |
|
783
Aldeyra Therapeutics
ALDX
$94.7M
| $265K | ﹤0.01% |
59,706
-7,517
| -11% | -$29.9K |
|
784
Nike
NKE
$62.3B
| $263K | ﹤0.01% |
1,956
-2,947
| -60% | -$414K |
|
785
VistaGen Therapeutics
VTGN
$9.36M
| $263K | ﹤0.01% |
7,075
-629
| -8% | -$27.4K |
|
786
Travelers Companies
TRV
$81.4B
| $257K | ﹤0.01% |
1,406
-441
| -24% | -$75.6K |
|
|
787
Williams Companies
WMB
$87.2B
| $254K | ﹤0.01% |
7,591
-1,171,193
| -99% | -$35.8M |
|
788
Clene
CLNN
$69.1M
| $252K | ﹤0.01% |
3,202
-397
| -11% | -$24K |
|
789
Altimmune
ALT
$580M
| $249K | ﹤0.01% |
40,836
-5,148
| -11% | -$37.9K |
|
790
Uber
UBER
$139B
| $249K | ﹤0.01% |
+6,984
| New | +$251K |
|
|
IMMP
791
Immutep
IMMP
$57.5M
| $244K | ﹤0.01% |
89,102
-13,222
| -13% | -$37.5K |
|
792
Viking Therapeutics
VKTX
$4.16B
| $242K | ﹤0.01% |
80,540
-9,999
| -11% | -$35.9K |
|
793
Comcast
CMCSA
$81.5B
| $230K | ﹤0.01% |
4,903
-1,521
| -24% | -$73.3K |
|
794
Analog Devices
ADI
$182B
| $224K | ﹤0.01% |
1,356
-2,559
| -65% | -$415K |
|
795
Douglas Elliman
DOUG
$160M
| $221K | ﹤0.01% |
31,792
-4,021
| -11% | -$30.5K |
|
796
Amdocs
DOX
$5.67B
| $216K | ﹤0.01% |
2,631
-819
| -24% | -$64.2K |
|
797
Lennar Class A
LEN
$20.5B
| $216K | ﹤0.01% |
2,744
-330
| -11% | -$29.7K |
|
798
Kimco Realty
KIM
$17.8B
| $213K | ﹤0.01% |
8,616
-2,673
| -24% | -$64.5K |
|
799
Tyler Technologies
TYL
$13B
| $209K | ﹤0.01% |
470
-190
| -29% | -$85.4K |
|
800
Middleby
MIDD
$6.11B
| $207K | ﹤0.01% |
1,262
+175
| +16% | +$31.8K |
|
Similar funds
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, ALPS Advisors held 1,043 positions worth $9.22B, up 3.7% from $8.89B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
ALPS Advisors withdrew a net $371M in Q1 2022, closing 210 positions and reducing 486 holdings. Its most notable exit was Western Midstream Partners, an estimated $541M position sold in full.
By sector, the portfolio is most concentrated in Energy at 66% of assets, up from 59% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, ALPS Advisors opened a new position in Lucid Motors worth $40.8M.
- ALPS Advisors's largest Q1 2022 buy was Lucid Motors: 160,553 shares worth $40.8M.
- ALPS Advisors added most to Hess Midstream in Q1 2022, an estimated $149M increase.
- ALPS Advisors's biggest Q1 2022 reduction was Williams Companies, cutting an estimated $35.8M.
- ALPS Advisors fully exited Western Midstream Partners in Q1 2022, selling an estimated $541M.
- ALPS Advisors's ten largest holdings make up 56% of its $9.22B portfolio in Q1 2022.
- ALPS Advisors opened 155 new positions and closed 210 in Q1 2022.
- ALPS Advisors's portfolio value rose 3.7% quarter-over-quarter to $9.22B.
Based on ALPS Advisors's 13F filing for Q1 2022, filed 16 May 2022.